(Q34249148)

31 July 2017

title

Detection of serum tumor markers in multiple myeloma using the CLINPROT system (English)

1 reference

31 July 2017

1 reference

Aili He

1

1 reference

31 July 2017

Ju Bai

2

1 reference

31 July 2017

Chen Huang

3

1 reference

31 July 2017

Juan Yang

4

1 reference

31 July 2017

Wanggang Zhang

5

1 reference

31 July 2017

Jianli Wang

6

1 reference

31 July 2017

Yun Yang

7

1 reference

31 July 2017

Pengyu Zhang

8

1 reference

31 July 2017

Fuling Zhou

9

1 reference

31 July 2017

publication date

27 April 2012

1 reference

International Journal of Hematology

31 July 2017

published in

1 reference

31 July 2017

volume

95

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

668-674

1 reference

Conventional diagnostics in multiple myeloma

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1080-3

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1080-3

Multiple myeloma: present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1080-3

Current treatment strategies for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1080-3

Molecular pathogenesis and a consequent classification of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1080-3

Improved survival in multiple myeloma and the impact of novel therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1080-3

Recent major improvement in long-term survival of younger patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1080-3

High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1080-3

High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1080-3

Construction of a multiple myeloma diagnostic model by magnetic bead-based MALDI-TOF mass spectrometry of serum and pattern recognition software

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1080-3

Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1080-3

Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1080-3

A search for novel markers of alcohol abuse using magnetic beads and MALDI-TOF/TOF mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1080-3

Proteomic-based prediction of clinical behavior in adult acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1080-3

A systematic review of molecular and biological markers in tumours of the Ewing's sarcoma family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1080-3

Role of tumor markers in patients with solid cancers: A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1080-3

The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1080-3

Biomarkers that discriminate multiple myeloma patients with or without skeletal involvement detected using SELDI-TOF mass spectrometry and statistical and machine learning tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1080-3

Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy.

21 January 2018

1 reference

12 December 2020

Poor outcome with front-line autologous transplantation in t(4;14) multiple myeloma: low complete remission rate and short duration of remission

1 reference

12 December 2020

Serum profiling reveals distinctive proteomic markers in chronic myeloid leukaemia patients

1 reference

12 December 2020

1 reference

12 December 2020

Serum proteome profiling for ovarion cancer diagnosis using ClinProt magnetic bead technique and MALDI-TOF-mass-spectrometry

1 reference

12 December 2020

Fishing for biomarkers: analyzing mass spectrometry data with the new ClinProTools software

1 reference

12 December 2020

Relationship Between Depth of Response and Outcome in Multiple Myeloma

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S12185-012-1080-3

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1033257342

0 references

Fatcat ID

release_nzkmeqeqendb7mogjdqz5yh3ae

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nzkmeqeqendb7mogjdqz5yh3ae

24 November 2022

mapped directly with Wikidata item

1 reference